Gadeta B.V.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bayer, Twist Collaboration Gives German

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Mersana Ends 2022 With Third Big Pharma

As the first companies with commercial chimeric antigen receptor T-cell (CAR-T) therapies, Novartis AG and Gilead Sciences Inc. , via its Kite Pharma Inc. subsidiary, are under pressure to show t

In a summer slowdown, biopharmaceutical start-up fundraising declined 27% in the third quarter of 2018, but Gossamer Bio Inc. and Orchard Therapeutics Ltd. brought in large venture capital rounds